---
figid: PMC2697807__bph0157-0234-f7
figtitle: Schematic illustration of the proposed stimulation of HAS isoform regulation
  by prostaglandins in cancer cells
organisms:
- NA
pmcid: PMC2697807
filename: bph0157-0234-f7.jpg
figlink: /pmc/articles/PMC2697807/figure/fig07/
number: F7
caption: Schematic illustration of the proposed stimulation of HAS isoform regulation
  by prostaglandins in cancer cells. According to our working hypothesis COX2-dependent
  prostaglandins (PGI2 and PGE2) activate the Gαs-coupled IP and EP2/4 receptors,
  raise intracellular cAMP levels and in turn activate HAS1 and HAS2 expression via
  PKA-mediated signals. The increased HA secretion stimulates a malignant tumour cell
  phenotype through signalling via HA receptors CD44 or receptor of HA-mediated motility
  (RHAMM). The present findings indicate that in oesophageal squamous cancer cells,
  OSC1 and OSC2, stimulation of HAS1 and HAS2 expression by prostaglandins is inhibited
  either at the level of prostaglandin receptor-stimulated cAMP induction (OSC2) and/or
  downstream of cAMP (OSC1, OSC2).
papertitle: Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from
  the prostaglandin–cAMP pathway.
reftext: S Twarock, et al. Br J Pharmacol. 2009 May;157(2):234-243.
year: '2009'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9524696
figid_alias: PMC2697807__F7
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Danio rerio
- Homo sapiens
redirect_from: /figures/PMC2697807__F7
ndex: 0055ac19-de91-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2697807__bph0157-0234-f7.html
  '@type': Dataset
  description: Schematic illustration of the proposed stimulation of HAS isoform regulation
    by prostaglandins in cancer cells. According to our working hypothesis COX2-dependent
    prostaglandins (PGI2 and PGE2) activate the Gαs-coupled IP and EP2/4 receptors,
    raise intracellular cAMP levels and in turn activate HAS1 and HAS2 expression
    via PKA-mediated signals. The increased HA secretion stimulates a malignant tumour
    cell phenotype through signalling via HA receptors CD44 or receptor of HA-mediated
    motility (RHAMM). The present findings indicate that in oesophageal squamous cancer
    cells, OSC1 and OSC2, stimulation of HAS1 and HAS2 expression by prostaglandins
    is inhibited either at the level of prostaglandin receptor-stimulated cAMP induction
    (OSC2) and/or downstream of cAMP (OSC1, OSC2).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COX2
  - egr
  - Pgi
  - ac
  - oc
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - ha
  - tnfa
  - tnfb
  - gpia
  - gpib
  - kita
  - ngfra
  - pak2a
  - itpka
  - bglapl
  - has1
  - has2
  - PTGS2
  - TNF
  - BGN
  - GPI
  - PGPEP1
  - PTGER3
  - PTGER2
  - SPAG11B
  - PTGER4
  - PTGER1
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - ONECUT2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - HAS1
  - DDX18
  - HNF1A-AS1
  - HAS2
  - forskolin
  - PGE
  - PGE2
---
